4//SEC Filing
Friedman Charlene A 4
Accession 0001181431-12-016909
CIK 0001401923other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:12 PM ET
Size
8.3 KB
Accession
0001181431-12-016909
Insider Transaction Report
Form 4
Friedman Charlene A
VP President, Gen Counsel &Sec
Transactions
- Sale
Common Stock
2012-03-09$17.50/sh−10,000$175,000→ 1,307 total - Exercise/Conversion
Common Stock
2012-03-09$12.37/sh+10,000$123,723→ 11,307 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-03-09−10,000→ 22,328 totalExercise: $12.37Exp: 2017-07-23→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The sale of the reported shares is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares.
- [F2]The option is exercisable as it vests: 25% of the total number of option shares vests and becomes exercisable on the first anniversary of the vesting commencement date. Thereafter, 1/48th of the total number of option shares becomes exercisable cumulatively on each monthly anniversary for 36 months so that the entire number of option shares becomes fully vested.
Documents
Issuer
MAP Pharmaceuticals, Inc.
CIK 0001401923
Entity typeother
Related Parties
1- filerCIK 0001413748
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:12 PM ET
- Size
- 8.3 KB